
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3B | $2.4B | $2.2B | $3B | $3.1B | |
Revenue Growth (YoY) | 50.82% | -19.57% | -6.5% | 34.58% | 3.5% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $204.4M | $226M | $201.4M | $269.6M | $294.4M | |
Other Inc / (Exp) | $1.3B | $450.8M | -$25.3M | $81.2M | $86.6M | |
Operating Expenses | $1.1B | $1.1B | $1B | $1.1B | $1.1B | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $472.8M | $945.4M | $1.2B | $1.6B | $1.6B | |
Earnings of Discontinued Ops. | -$418M | $100.6M | $242.6M | -- | -- | |
Income Tax Expense | $14.8M | $17.7M | $277.4M | $400.6M | $385.3M | |
Net Income to Company | $76.5M | $1.1B | $1.5B | $1.6B | $1.6B | |
Minority Interest in Earnings | -$2.3M | -$2.4M | -$2.1M | -$3.2M | -$3.2M | |
Net Income to Common Excl Extra Items | $37.7M | $1B | $1.2B | $1.2B | $1.3B | |
Basic EPS (Cont. Ops) | $0.05 | $1.12 | $1.29 | $1.31 | $1.37 | |
Diluted EPS (Cont. Ops) | $0.05 | $1.12 | $1.29 | $1.31 | $1.37 | |
Weighted Average Basic Share | $914.5M | $914.6M | $914.7M | $914.6M | $912.2M | |
Weighted Average Diluted Share | $914.5M | $914.6M | $914.7M | $914.6M | $912.2M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $708.1M | $1.1B | $1.4B | $2.2B | $2.4B | |
Revenue (Reported) | $3B | $2.4B | $2.2B | $3B | $3.1B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $708.1M | $1.1B | $1.4B | $2.2B | $2.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1B | $510.6M | $680.9M | $829.9M | $712.4M | |
Revenue Growth (YoY) | -14.53% | -50.39% | 33.37% | 21.87% | -14.16% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $57.8M | $53.9M | $52.6M | $60.8M | $61M | |
Other Inc / (Exp) | $297.6M | $9M | $67.7M | $64.1M | $50.5M | |
Operating Expenses | $251.8M | $225.5M | $238.4M | $256.3M | $251.5M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $614.6M | $177.3M | $385.6M | $519.2M | $419.8M | |
Earnings of Discontinued Ops. | $61.5M | $269.3M | -- | -- | -- | |
Income Tax Expense | $3.6M | $41.5M | $105.3M | $129.3M | $102.1M | |
Net Income to Company | $686.9M | $454.5M | $385.6M | $519.2M | $419.8M | |
Minority Interest in Earnings | -$1.2M | -$1.1M | -$1.1M | -$1.1M | -$1.1M | |
Net Income to Common Excl Extra Items | $671.2M | $404M | $279.2M | $388.9M | $316.7M | |
Basic EPS (Cont. Ops) | $0.74 | $0.44 | $0.30 | $0.42 | $0.35 | |
Diluted EPS (Cont. Ops) | $0.74 | $0.44 | $0.30 | $0.42 | $0.35 | |
Weighted Average Basic Share | $914.6M | $914.7M | $914.7M | $913.2M | $911.9M | |
Weighted Average Diluted Share | $914.6M | $914.7M | $914.7M | $913.2M | $911.9M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $662.8M | $219.9M | $462.9M | $715.8M | $567.2M | |
Revenue (Reported) | $1B | $510.6M | $680.9M | $829.9M | $712.4M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $662.8M | $219.9M | $462.9M | $715.8M | $567.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.8B | $1.8B | $2.3B | $2.9B | $2.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $206.5M | -- | -- | -- | -- | |
Other Inc / (Exp) | $1.1B | $9M | $73.7M | $64.1M | $53.8M | |
Operating Expenses | $1.1B | $1B | $897.5M | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $736M | $581.5M | $1.1B | $1.8B | $1.7B | |
Earnings of Discontinued Ops. | -$379M | $241.6M | -$37M | -- | -- | |
Income Tax Expense | $13.9M | $55.5M | $279.8M | $424.5M | $358.9M | |
Net Income to Company | $423.5M | $833.6M | $1.4B | $1.7B | $1.5B | |
Minority Interest in Earnings | -$2.4M | -$1.1M | -$2.1M | -$2.2M | -$2.2M | |
Net Income to Common Excl Extra Items | $340.7M | $766.4M | $1.1B | $1.3B | $1.2B | |
Basic EPS (Cont. Ops) | $0.38 | $0.83 | $1.16 | $1.44 | $1.30 | |
Diluted EPS (Cont. Ops) | $0.38 | $0.83 | $1.16 | $1.44 | $1.30 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $953.6M | $713.5M | $1.3B | $2.3B | $2.3B | |
Revenue (Reported) | $2.8B | $1.8B | $2.3B | $2.9B | $2.9B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $953.6M | $713.5M | $1.3B | $2.3B | $2.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1B | $510.6M | $680.9M | $829.9M | $712.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $57.8M | $53.9M | $52.6M | $60.8M | $61M | |
Other Inc / (Exp) | $297.6M | $9M | $67.7M | $64.1M | $50.5M | |
Operating Expenses | $251.8M | $225.5M | $238.4M | $256.3M | $251.5M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $614.6M | $177.3M | $385.6M | $519.2M | $419.8M | |
Earnings of Discontinued Ops. | $61.5M | $269.3M | -- | -- | -- | |
Income Tax Expense | $3.6M | $41.5M | $105.3M | $129.3M | $102.1M | |
Net Income to Company | $686.9M | $454.5M | $385.6M | $519.2M | $419.8M | |
Minority Interest in Earnings | -$1.2M | -$1.1M | -$1.1M | -$1.1M | -$1.1M | |
Net Income to Common Excl Extra Items | $671.2M | $404M | $279.2M | $388.9M | $316.7M | |
Basic EPS (Cont. Ops) | $0.74 | $0.44 | $0.30 | $0.42 | $0.35 | |
Diluted EPS (Cont. Ops) | $0.74 | $0.44 | $0.30 | $0.42 | $0.35 | |
Weighted Average Basic Share | $914.6M | $914.7M | $914.7M | $913.2M | $911.9M | |
Weighted Average Diluted Share | $914.6M | $914.7M | $914.7M | $913.2M | $911.9M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | $662.8M | $219.9M | $462.9M | $715.8M | $567.2M | |
Revenue (Reported) | $1B | $510.6M | $680.9M | $829.9M | $712.4M | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | $662.8M | $219.9M | $462.9M | $715.8M | $567.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $16.2B | $22.6B | $18.6B | $13.3B | $8.2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $51.7M | $39.6M | $52.5M | $64.1M | $59.3M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $24.5B | $32.4B | $28.3B | $20.3B | $13.5B | |
Property Plant And Equipment | $2B | $1.9B | $1.7B | $1.5B | $1.3B | |
Long-Term Investments | $26.3B | $22.2B | $16.9B | $21.5B | $23.5B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $346.8M | $399.7M | $462.2M | $579.2M | $651.4M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $95.3B | $95.1B | $83.8B | $82.4B | $78B | |
Accounts Payable | $4.9M | $3.4M | $8.6M | $67.4M | $14.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $412M | $343.1M | $371.1M | $467.6M | $385M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $89B | $88.5B | $76.8B | $74B | $69.2B | |
Common Stock | $3.4B | $1B | $981.2M | $1B | $952.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $6.2B | $6.5B | $6.9B | $8.4B | $8.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $24.6M | $24.9M | $24.7M | $28.7M | $30.2M | |
Total Equity | $6.3B | $6.5B | $6.9B | $8.5B | $8.8B | |
Total Liabilities and Equity | $95.3B | $95.1B | $83.8B | $82.4B | $78B | |
Cash and Short Terms | $16.2B | $22.6B | $18.6B | $13.3B | $8.2B | |
Total Debt | $2.7B | $2.5B | $3.2B | $3.4B | $4.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $15.8B | $20.4B | $13.8B | $11.7B | $9.3B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $21.7B | $30.6B | $22.3B | $16.9B | $14B | |
Property Plant And Equipment | $1.9B | $1.9B | $1.8B | $1.4B | $1.4B | |
Long-Term Investments | $25.3B | $20B | $18.8B | $21.2B | $24.4B | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $91.8B | $89.5B | $82.1B | $78.2B | $81.5B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $3.5M | $5.6M | $3.3M | $8.6M | $8.7M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $85.4B | $83B | $74.7B | $69.6B | $72B | |
Common Stock | $3.2B | $1B | $997.8M | $988.1M | $990.3M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $24.6M | $24.6M | $26.2M | $28.1M | $32.5M | |
Total Equity | $6.4B | $6.5B | $7.4B | $8.6B | $9.5B | |
Total Liabilities and Equity | $91.8B | $89.5B | $82.1B | $78.2B | $81.5B | |
Cash and Short Terms | $15.8B | $20.4B | $13.8B | $11.7B | $9.3B | |
Total Debt | $1.2B | $1.1B | $2B | $3.5B | $4B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $76.5M | $1.1B | $1.5B | $1.6B | $1.6B | |
Depreciation & Amoritzation | $175.9M | $192.9M | $181.4M | $203.5M | $201.3M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $12.7B | $7.8B | $2B | -$5.2B | -$2.7B | |
Capital Expenditures | $203.3M | $211.8M | -- | -- | -- | |
Cash Acquisitions | $46.8M | -- | $62.2M | $1.1M | -$56.3M | |
Cash From Investing | -$5.7B | -$321.8M | -$1.1B | -$3.4B | -$3.1B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$359.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $637.3M | $22.5M | $956.5M | $599.8M | $1.9B | |
Long-Term Debt Repaid | -$1.1B | -- | -$65.4M | -- | -$611.5M | |
Repurchase of Common Stock | -$19.4M | -$17.7M | -$14.8M | -$18.4M | -$40M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$517.3M | -$43.8M | $827.9M | $530.5M | $858.3M | |
Beginning Cash (CF) | $4.7B | $11.6B | $16.5B | $18.6B | $10.6B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.4B | $7.5B | $1.7B | -$8B | -$5B | |
Ending Cash (CF) | $11.2B | $19.1B | $18.2B | $10.6B | $5.6B | |
Levered Free Cash Flow | $12.5B | $7.6B | $2B | -$5.2B | -$2.7B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $686.9M | $454.5M | $385.6M | $519.2M | $419.8M | |
Depreciation & Amoritzation | $48.2M | $46M | $49.4M | $50M | $51.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.4B | $2.6B | -$3.1B | -$2.4B | $1.8B | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | $159.3M | -- | -- | -- | |
Cash From Investing | -$2.1B | -$529.6M | -$1.4B | -$369.3M | -$493.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $23.6M | $1.2B | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$355.2M | -$2.1M | |
Repurchase of Common Stock | -$4.8M | -$23.6M | -$20.4M | -$11.9M | -$4.2M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$14.5M | -$16.8M | $6.4M | $819M | -$15.8M | |
Beginning Cash (CF) | $11.8B | $18.1B | $18.5B | $10.6B | $5.4B | |
Foreign Exchange Rate Adjustment | -$7.2M | -$2.2M | -$8.6M | -$19.6M | -$4.2M | |
Additions / Reductions | $1.3B | $2.1B | -$4.6B | -$1.9B | $1.3B | |
Ending Cash (CF) | $13.1B | $20.1B | $13.9B | $8.7B | $6.7B | |
Levered Free Cash Flow | $3.4B | $2.6B | -$3.1B | -$2.4B | $1.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $423.5M | $833.6M | $1.4B | $1.7B | $1.5B | |
Depreciation & Amoritzation | $182.1M | $190.7M | $184.8M | $204.1M | $202.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $12.1B | $7B | -$3.7B | -$4.4B | $1.5B | |
Capital Expenditures | $203.3M | -- | -- | -- | -- | |
Cash Acquisitions | $46.8M | $159.3M | -$97.1M | $1.1M | -$56.3M | |
Cash From Investing | -$6.1B | $1.2B | -$2B | -$2.3B | -$3.3B | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$359.3M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $22.5M | $980.1M | $1.8B | $705.8M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -$258.4M | |
Repurchase of Common Stock | -$20.9M | -$36.5M | -$11.6M | -$9.9M | -$32.3M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$509.7M | -$46.1M | $851.1M | $1.3B | $23.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $5.5B | $8.2B | -$4.9B | -$5.4B | -$1.8B | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $11.9B | $7B | -$3.7B | -$4.4B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $686.9M | $454.5M | $385.6M | $519.2M | $419.8M | |
Depreciation & Amoritzation | $48.2M | $46M | $49.4M | $50M | $51.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3.4B | $2.6B | -$3.1B | -$2.4B | $1.8B | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | $159.3M | -- | -- | -- | |
Cash From Investing | -$2.1B | -$529.6M | -$1.4B | -$369.3M | -$493.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $23.6M | $1.2B | -- | |
Long-Term Debt Repaid | -- | -- | -- | -$355.2M | -$2.1M | |
Repurchase of Common Stock | -$4.8M | -$23.6M | -$20.4M | -$11.9M | -$4.2M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$14.5M | -$16.8M | $6.4M | $819M | -$15.8M | |
Beginning Cash (CF) | $11.8B | $18.1B | $18.5B | $10.6B | $5.4B | |
Foreign Exchange Rate Adjustment | -$7.2M | -$2.2M | -$8.6M | -$19.6M | -$4.2M | |
Additions / Reductions | $1.3B | $2.1B | -$4.6B | -$1.9B | $1.3B | |
Ending Cash (CF) | $13.1B | $20.1B | $13.9B | $8.7B | $6.7B | |
Levered Free Cash Flow | $3.4B | $2.6B | -$3.1B | -$2.4B | $1.8B |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.